Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

1.

Transient left homonymous hemianopsia and encephalopathy following treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin.

Cohen RJ, Cuneo RA, Cruciger MP, Jackman AE.

J Clin Oncol. 1983 Jun;1(6):392-3.

PMID:
6199475
[PubMed - indexed for MEDLINE]
Free Article
2.

Transient left homonymous hemianopsia during treatment of testicular carcinoma with cisplatinum, vinblastine, and bleomycin.

Crispino S, Pizzocaro G, Solero CL, Rodari A, Monfardini S.

Chemioterapia. 1984 Oct;3(5):337-9.

PMID:
6085288
[PubMed - indexed for MEDLINE]
3.

Encephalopathy following cisplatin, bleomycin and vinblastine therapy for non-seminomatous germ cell tumour of testis.

Hitchins RN, Thomson DB.

Aust N Z J Med. 1988 Feb;18(1):67-8.

PMID:
2456056
[PubMed - indexed for MEDLINE]
4.

Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.

Mead GM, Green JA, Macbeth FR, Williams CJ, Whitehouse JM, Buchanan R.

Cancer Treat Rep. 1983 Apr;67(4):410. No abstract available.

PMID:
6189603
[PubMed - indexed for MEDLINE]
5.

Hemorrhagic cystitis after i.v. bleomycin, vinblastine, cisplatin, and etoposide for testicular cancer.

Cantwell BM, Harris AL, Patrick D, Hall RR.

Cancer Treat Rep. 1986 Apr;70(4):548-9. No abstract available.

PMID:
2421895
[PubMed - indexed for MEDLINE]
6.

Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.

Rees GJ, Slade RR, Hopes P.

Eur J Cancer Clin Oncol. 1982 Nov;18(11):1125-9.

PMID:
6186497
[PubMed - indexed for MEDLINE]
7.

Inclusion of cisplatinum (cis-DDP, Platidiam, Lachema) into combined chemotherapeutic protocol for the treatment of testicular cancer.

Bodrogi I, Baki M, Hindy I, Eckhardt S.

Neoplasma. 1983;30(5):557-61.

PMID:
6197662
[PubMed - indexed for MEDLINE]
8.

A case of nonseminomatous testicular tumor with liver metastases, treated by intrahepatic arterial cisplatinum-diaminedichloride infusion.

Kawai K, Sasaki A, Nishijima Y, Kikuchi K, Ohtani M, Rinshou K, Koiso K, Adachi S, Ishikawa A, Iwasaki Y.

Eur Urol. 1990;18(3):234-6.

PMID:
1702060
[PubMed - indexed for MEDLINE]
9.

Acute nonlymphocytic leukemia 5 years after treatment with cisplatin, vinblastine, and bleomycin for disseminated testicular cancer.

van Imhoff GW, Sleijfer DT, Breuning MH, Anders GJ, Mulder NH, Halie MR.

Cancer. 1986 Mar 1;57(5):984-7.

PMID:
2417690
[PubMed - indexed for MEDLINE]
10.

Late relapse after adjuvant chemotherapy for stage II testicular cancer.

Weiss RB, Natale RB, Sesterhenn IA.

N Engl J Med. 1990 Aug 2;323(5):350. No abstract available.

PMID:
1694968
[PubMed - indexed for MEDLINE]
Free Article
11.

Acute ileotyphlitis as a complication of cytotoxic drug treatment of a non-seminomatous germ cell tumor of the testis.

Beadle GF.

Aust N Z J Med. 1990 Aug;20(4):594-5.

PMID:
1699516
[PubMed - indexed for MEDLINE]
12.

Acute vascular toxicity after combination chemotherapy with cisplatin, vinblastine, and bleomycin for testicular cancer.

Stefenelli T, Kuzmits R, Ulrich W, Glogar D.

Eur Heart J. 1988 May;9(5):552-6.

PMID:
2456930
[PubMed - indexed for MEDLINE]
13.

Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.

Berger CC, Bokemeyer C, Schneider M, Kuczyk MA, Schmoll HJ.

Eur J Cancer. 1995 Dec;31A(13-14):2229-38.

PMID:
8652248
[PubMed - indexed for MEDLINE]
14.

Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.

Stoter G, Vendrik CP, Struyvenberg A, Sleyfer DT, Vriesendorp R, Schraffordt Koops H, van Oosterom AT, ten Bokkel Huinink WW, Pinedo HM.

Cancer. 1984 Oct 15;54(8):1521-4.

PMID:
6206937
[PubMed - indexed for MEDLINE]
15.

Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer.

Hansen SW, Helweg-Larsen S, Trojaborg W.

J Clin Oncol. 1989 Oct;7(10):1457-61.

PMID:
2476531
[PubMed - indexed for MEDLINE]
Free Article
16.

Curative, platinum-based cytoxic drug therapy in a renal transplant recipient with metastatic testicular cancer.

Osiason AW, Polackwich RJ.

Cancer. 1986 Aug 15;58(4):850-1.

PMID:
2424586
[PubMed - indexed for MEDLINE]
17.

Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer.

Eeles R, Tait DM, Peckham MJ.

Cancer Treat Rep. 1986 Jul;70(7):905-7.

PMID:
2424594
[PubMed - indexed for MEDLINE]
18.

Vinblastine, cisplatin and bleomycin (VPB) adjuvant therapy does not induce dose-dependent damage in human chromosomes.

Gundy S, Baki M, Bodrogi I.

Neoplasma. 1989;36(4):457-64.

PMID:
2475796
[PubMed - indexed for MEDLINE]
19.

Chemotherapy of advanced testicular cancer.

Williams SD, Loehrer PJ Sr, Einhorn LH.

Semin Urol. 1984 Nov;2(4):230-7. No abstract available.

PMID:
6209762
[PubMed - indexed for MEDLINE]
20.

Early myocardial infarction during chemotherapy for testicular cancer.

Bachmeyer C, Joly H, Jorest R.

Tumori. 2000 Sep-Oct;86(5):428-30.

PMID:
11130576
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk